Skip to Main content Skip to Navigation
Journal articles

Tick Salivary Compounds for Targeted Immunomodulatory Therapy

Abstract : Immunodeficiency disorders and autoimmune diseases are common, but a lack of effective targeted drugs and the side-effects of existing drugs have stimulated interest in finding therapeutic alternatives. Naturally derived substances are a recognized source of novel drugs, and tick saliva is increasingly recognized as a rich source of bioactive molecules with specific functions. Ticks use their saliva to overcome the innate and adaptive host immune systems. Their saliva is a rich cocktail of molecules including proteins, peptides, lipid derivatives, and recently discovered non-coding RNAs that inhibit or modulate vertebrate immune reactions. A number of tick saliva and/or salivary gland molecules have been characterized and shown to be promising candidates for drug development for vertebrate immune diseases. However, further validation of these molecules at the molecular, cellular, and organism levels is now required to progress lead candidates to clinical testing. In this paper, we review the data on the immunopharmacological aspects of tick salivary compounds characterized in vitro and/or in vivo and present recent findings on non-coding RNAs that might be exploitable as immunomodulatory therapies.
Document type :
Journal articles
Complete list of metadata

https://hal-riip.archives-ouvertes.fr/pasteur-03565974
Contributor : AbdelHakim Ben Hassine Connect in order to contact the contributor
Submitted on : Friday, February 11, 2022 - 12:06:51 PM
Last modification on : Wednesday, February 16, 2022 - 3:46:13 PM
Long-term archiving on: : Thursday, May 12, 2022 - 6:36:16 PM

File

bbb.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Hajer Aounallah, Chaima Bensaoud, Youmna M’ghirbi, Fernanda Faria, Jindr̆ich Chmelar̆, et al.. Tick Salivary Compounds for Targeted Immunomodulatory Therapy. Frontiers in Immunology, Frontiers, 2020, 11, pp.583845. ⟨10.3389/fimmu.2020.583845⟩. ⟨pasteur-03565974⟩

Share

Metrics

Record views

5

Files downloads

2